Patients with comorbid diabetes have an elevated risk for lower extremity amputation (LEA) at all stages of chronic kidney ...

Novo Nordisk's SOUL trial reveals a 14% reduction in major cardiovascular events with oral semaglutide in patients with type ...

Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...

I'm offended.” Ozempic was first approved in 2017 by the US Food and Drug Administration (FDA) as an injectable drug to help ...

Sotagliflozin is used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.

Cancer, malaria and pneumonia continue to be some of Kenya’s biggest health challenges despite the scale-up of intervention tools, and that is expected to be the case in coming years.

The initial donation of €200,000 (approximately $220,000) will be increased by a further €200,000 donations to LEVF during ...

AN INSIGHTFUL session on the future of lung transplantation presented at this year’s European Respiratory Society (ERS) ...

Early control of HbA1c levels and weight in people with diabetes significantly reduces cardiac disease risk. Delays in ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

More than 20,000 were diagnosed with such injuries last year, the Defense Department's Traumatic Brain Injury Center of ...